Horn L - Search Results

1

Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients.

Ou SI, Horn L, Cruz M, Vafai D, Lovly CM, Spradlin A, Williamson MJ, Dagogo-Jack I, Johnson A, Miller VA, Gadgeel S, Ali SM, Schrock AB. Ou SI, et al. Among authors: horn l. Lung Cancer. 2017 Sep;111:61-64. doi: 10.1016/j.lungcan.2017.07.006. Epub 2017 Jul 11. Lung Cancer. 2017. PMID: 28838400 Free PMC article.

2

Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Clin Lung Cancer. 2009 Mar;10 Suppl 1(Suppl 1):S7-16. doi: 10.3816/CLC.2009.s.002. Clin Lung Cancer. 2009. PMID: 19362948 Free PMC article. Review.

3

A phase II study of carboplatin and irinotecan in extensive stage small-cell lung cancer.

Horn L, Zhao Z, Sandler A, Johnson D, Shyr Y, Wolff S, Devore RF, Laskin J. Horn L, et al. Clin Lung Cancer. 2011 May;12(3):161-5. doi: 10.1016/j.cllc.2011.03.013. Epub 2011 Apr 27. Clin Lung Cancer. 2011. PMID: 21663858 Clinical Trial.

4

Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.

Horn L, Keedy VL, Campbell N, Garcia G, Hayes A, Spencer B, Carbone DP, Sandler A, Johnson DH. Horn L, et al. Clin Lung Cancer. 2013 Jan;14(1):14-8. doi: 10.1016/j.cllc.2012.03.008. Epub 2012 May 15. Clin Lung Cancer. 2013. PMID: 22591607

5

Strategies for overcoming EGFR resistance in the treatment of advanced-stage NSCLC.

Lovly CM, Horn L. Lovly CM, et al. Among authors: horn l. Curr Treat Options Oncol. 2012 Dec;13(4):516-26. doi: 10.1007/s11864-012-0204-6. Curr Treat Options Oncol. 2012. PMID: 22833206

6

Update on HER1-3 in advanced non-small-cell lung cancer.

Horn L, Lovly C. Horn L, et al. J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S369-71. doi: 10.1097/JTO.0b013e31826defaa. J Thorac Oncol. 2012. PMID: 23160321 Free article. Review. No abstract available.

7

DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.

Yeh P, Chen H, Andrews J, Naser R, Pao W, Horn L. Yeh P, et al. Among authors: horn l. Clin Cancer Res. 2013 Apr 1;19(7):1894-901. doi: 10.1158/1078-0432.CCR-12-1894. Epub 2013 Jan 23. Clin Cancer Res. 2013. PMID: 23344264 Free PMC article.

8

A 75-year-old man with progressive bronchioalveolar carcinoma.

Baikadi M, Lovly C, Horn L, Reckamp KL, Noonan K, Laskin J, Morris GJ. Baikadi M, et al. Among authors: horn l. Semin Oncol. 2013 Feb;40(1):e1-8. doi: 10.1053/j.seminoncol.2012.11.004. Semin Oncol. 2013. PMID: 23391120 Free PMC article. No abstract available.

9

A patient with metastatic lung adenocarcinoma harboring concurrent EGFR L858R, EGFR germline T790M, and PIK3CA mutations: the challenge of interpreting results of comprehensive mutational testing in lung cancer.

Lammers PE, Lovly CM, Horn L. Lammers PE, et al. Among authors: horn l. J Natl Compr Canc Netw. 2014 Jan;12(1):6-11; quiz 11. doi: 10.6004/jnccn.2014.0002. J Natl Compr Canc Netw. 2014. PMID: 24453288 Free PMC article.

10

Beyond histology: translating tumor genotypes into clinically effective targeted therapies.

Meador CB, Micheel CM, Levy MA, Lovly CM, Horn L, Warner JL, Johnson DB, Zhao Z, Anderson IA, Sosman JA, Vnencak-Jones CL, Dahlman KB, Pao W. Meador CB, et al. Among authors: horn l. Clin Cancer Res. 2014 May 1;20(9):2264-75. doi: 10.1158/1078-0432.CCR-13-1591. Epub 2014 Mar 5. Clin Cancer Res. 2014. PMID: 24599935 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,327 results

Search Page